Hurel Corp. Names MacDonald to Board
Hurel Corp., a provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, has named Dr. James S. MacDonald to its board of directors. Hurel recently secured a $9.2 million Series A equity private placement led by Spring Mountain Capital. Hurel is based in both North Brunswick, NJ and Beverly Hills, Calif.


